{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:10:39Z","timestamp":1791497439851,"version":"4.3.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>The 5th edition of the WHO classification of haematolymphoid tumours introduces the concept of hyperplasias arising in immune deficiency and dysregulation (IDD), which are frequently associated with Epstein-Barr virus (EBV). These lesions can be histologically classified as follicular hyperplasia (FH), infectious mononucleosis-like hyperplasia (IMH), or plasmacytic hyperplasia. Although EBV-associated reactive lymphoid hyperplasia (EBV-RLH) has been recognized in various IDD settings, comprehensive clinicopathologic analyses remain limited. We analyzed 34 Japanese patients with EBV-RLH. The IDD settings primarily included autoimmune diseases (with or without immunosuppressive therapy), chemotherapy for prior malignancies, aging, post-hematopoietic stem cell transplantation, and HIV infection. No patient exhibited histologic transformation or died due to EBV-RLH. Three patients had concurrent hematologic malignancies, and 12 had immune dysregulation related to prior chemotherapy. Histologically, 20 cases showed FH, 6 IMH, and 8 nonspecific patterns. EBER-positive cells were distributed in both interfollicular areas and germinal centers (GCs) in 27 cases (79%) and confined to interfollicular areas in 7. Six cases exhibited intensive aggregation of EBER-positive cells in one or a few GCs. Double staining confirmed that most EBER-positive cells expressed CD79a but not CD3. IGH and TCRG PCR analyses were successful in 24 cases: 21 were negative for both rearrangements, and 3 showed clonal rearrangements (1 double, 1 IGH-only, and 1 TCRG-only). EBV-RLH generally followed an indolent course; however, it may coexist with hematologic malignancies or develop after multichemotherapy. Careful histopathologic evaluation is essential to avoid overlooking concurrent malignancy or unnecessary treatment.<\/jats:p>","DOI":"10.1097\/pas.0000000000002505","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T05:01:34Z","timestamp":1767762094000},"page":"366-375","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathologic Analysis of 34 Japanese Patients With EBV-Associated Reactive Lymphoid Hyperplasias"],"prefix":"10.1097","volume":"50","author":[{"given":"Yuuki","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Satou","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute"},{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishi","family":"Takahara","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kobe City Hospital Organization, Kobe City Medical Center General Hospital, Kobe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Seki","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akari","family":"Iwakoshi","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Hospital Organization Nagoya Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Hematology and Immunology, Kanazawa Medical University, Uchinada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Immunology, Kanazawa Medical University, Uchinada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanae","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Cytology and Molecular Pathology, Japanese Red Cross Aichi Medical Center, Nagoya Daiichi Hospital, Nagoya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Cytology and Molecular Pathology, Japanese Red Cross Aichi Medical Center, Nagoya Daiichi Hospital, Nagoya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyonori","family":"Tsuzuki","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"R3-20260218","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ajcp\/aqw214","article-title":"EBV-positive B-cell proliferations of varied malignant potential: 2015 SH\/EAHP Workshop Report-Part 1","volume":"147","author":"Natkunam","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"R4-20260218","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood-2018-04-842559","article-title":"Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?","volume":"132","author":"Natkunam","year":"2018","journal-title":"Blood"},{"key":"R5-20260218","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"R6-20260218","doi-asserted-by":"crossref","first-page":"100441","DOI":"10.1016\/j.modpat.2024.100441","article-title":"Fifth Edition of the World Health classification of tumors of the hematopoietic and lymphoid tissues: B-cell neoplasms","volume":"37","author":"Medeiros","year":"2024","journal-title":"Mod Pathol"},{"key":"R7-20260218","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41375-022-01764-1","article-title":"A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas","volume":"37","author":"Falini","year":"2023","journal-title":"Leukemia"},{"key":"R8-20260218","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3960\/jslrt.22025","article-title":"Castleman disease and mimickers: Clinicopathological findings of atypical lymphoproliferative disorders associated with autoimmune disease","volume":"62","author":"Nakazato","year":"2022","journal-title":"J Clin Exp Hematop"},{"key":"R9-20260218","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"key":"R10-20260218","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1440-1827.2009.02466.x","article-title":"Age-related EBV-associated B-cell lymphoproliferative disorders: diagnostic approach to a newly recognized clinicopathological entity","volume":"59","author":"Shimoyama","year":"2009","journal-title":"Pathol Int"},{"key":"R11-20260218","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1002\/cam4.4198","article-title":"EBV-positive B-cell lymphomas and lymphoproliferative disorders: review from the perspective of immune escape and immunodeficiency","volume":"10","author":"Satou","year":"2021","journal-title":"Cancer Med"},{"key":"R12-20260218","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000332","article-title":"Epstein-Barr virus (EBV)-positive sporadic burkitt lymphoma: an age-related lymphoproliferative disorder?","volume":"39","author":"Satou","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R13-20260218","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.3390\/cancers14112647","article-title":"An update on the pathology and molecular features of Hodgkin lymphoma","volume":"14","author":"Satou","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R14-20260218","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3390\/diagnostics12061507","article-title":"Hodgkin lymphoma: biology and differential diagnostic problem","volume":"12","author":"Takahara","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R15-20260218","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ajcp\/aqw216","article-title":"B-cell and classical Hodgkin lymphomas associated with immunodeficiency: 2015 SH\/EAHP Workshop Report-Part 2","volume":"147","author":"de Jong","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"R16-20260218","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ajcp\/aqw213","article-title":"T- and NK-cell lymphomas and systemic lymphoproliferative disorders and the immunodeficiency setting: 2015 SH\/EAHP Workshop Report-Part 4","volume":"147","author":"Gratzinger","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"R17-20260218","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.pas.0000173238.17331.6b","article-title":"Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified","volume":"29","author":"Asano","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R18-20260218","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4132\/jptm.2019.08.06","article-title":"Multistaining optimization for Epstein-Barr virus-encoded RNA in situ hybridization and immunohistochemistry of formalin-fixed paraffin-embedded tissues using an automated immunostainer","volume":"53","author":"Ko","year":"2019","journal-title":"J Pathol Transl Med"},{"key":"R19-20260218","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"R20-20260218","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2169\/internalmedicine.9112-17","article-title":"EBV-positive reactive hyperplasia progressed into EBV-positive diffuse large B-cell lymphoma of the elderly over a 6-year period","volume":"57","author":"Kunitomi","year":"2018","journal-title":"Intern Med"},{"key":"R21-20260218","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.prp.2016.12.012","article-title":"Coexistence of age-related EBV-associated follicular hyperplasia and large B-cell EBV+ lymphoma of the elderly. Two distinct features of the same T-cell dysfunction related to senescence?","volume":"213","author":"Gibier","year":"2017","journal-title":"Pathol Res Pract"},{"key":"R22-20260218","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/his.13464","article-title":"Comparison of Epstein-Barr virus-positive mucocutaneous ulcer associated with treated lymphoma or methotrexate in Japan","volume":"72","author":"Daroontum","year":"2018","journal-title":"Histopathology"},{"key":"R23-20260218","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.5060","article-title":"Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia","volume":"245","author":"Garcia-Barchino","year":"2018","journal-title":"J Pathol"},{"key":"R24-20260218","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12308-016-0273-8","article-title":"Secondary B-cell lymphoma associated with the Epstein-Barr virus in chronic lymphocytic leukemia patients","volume":"9","author":"Morscio","year":"2016","journal-title":"J Hematop"},{"key":"R25-20260218","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2008-02-138800","article-title":"EBV-positive immunodeficiency lymphoma after alemtuzumab-CHOP therapy for peripheral T-cell lymphoma","volume":"112","author":"Kluin-Nelemans","year":"2008","journal-title":"Blood"},{"key":"R26-20260218","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAS.0000000000000954","article-title":"Cancer therapy-associated lymphoproliferative disorders: an under-recognized type of immunodeficiency-associated lymphoproliferative disorder","volume":"42","author":"Pina-Oviedo","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R27-20260218","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00296-023-05331-4","article-title":"Prevalence and clinical significance of lymphadenopathy and its histological subtypes in patients with systemic lupus erythematosus: a retrospective cohort study","volume":"43","author":"Papachristodoulou","year":"2023","journal-title":"Rheumatol Int"},{"key":"R28-20260218","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/147323000303100415","article-title":"Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus","volume":"31","author":"Calguneri","year":"2003","journal-title":"J Int Med Res"},{"key":"R29-20260218","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1440-1827.2000.01052.x","article-title":"Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases","volume":"50","author":"Kojima","year":"2000","journal-title":"Pathol Int"},{"key":"R30-20260218","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1600-0463.2005.apm_185.x","article-title":"Reactive hyperplasia with giant follicles in lymph node lesions from systemic lupus erythematosus patients. Report of three cases","volume":"113","author":"Kojima","year":"2005","journal-title":"APMIS"},{"key":"R31-20260218","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1615\/CritRevImmunol.v23.i12.30","article-title":"CD8 T cells and aging","volume":"23","author":"Effros","year":"2003","journal-title":"Crit Rev Immunol"},{"key":"R32-20260218","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.mad.2006.01.011","article-title":"Human cytomegalovirus infection and T cell immunosenescence: a mini review","volume":"127","author":"Koch","year":"2006","journal-title":"Mech Ageing Dev"},{"key":"R33-20260218","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00428-020-02967-6","article-title":"Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases","volume":"478","author":"Satou","year":"2021","journal-title":"Virchows Arch"},{"key":"R34-20260218","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fped.2019.00071","article-title":"Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases","volume":"7","author":"Kim","year":"2019","journal-title":"Front Pediatr"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:00:18Z","timestamp":1771394418000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002505","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"2025-07-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}